Table of Contents
The new report “Global Incontinence Care Products and Devices Market Assessment, Forecast 2015-2019” by Spearhead Acuity Business Research & Consulting group provides detailed insight into six different geographical regions of North America, Europe, Asia-Pacific, Latin America, Middle-East and Africa. North America continued to lead global incontinence care products and devices market with a share of 32.0% in 2014 that translated into revenues worth US$ 3,152.6 million.
Incontinence is the loss of control or involuntary evacuation of urine or feces that can occur due to multiple causes such as stress, nerve damage of sphincter, urge incontinence, overflow of bladder and pregnancy among some other types. The incontinence market consists of devices for prevention and treatment such as absorbent pads, urology catheters and bags, artificial sphincters, pessaries and clamps and devices that give therapeutic stimulation to nerves. Incontinence occurs in all ages and can affect a person at any point in their lives. Statistics show that close to 8 million people in U.K have suffered from urinary or fecal incontinence. Studies have indicated that over 38% women and 29% men have clinically significant symptoms of incontinence.
The report covers market analysis for a variety of different devices and products such as adult diapers (liners, briefs, pads, guards and drip collection), incontinence catheters (Foley, intermittent and male external catheters), urinary drainage bags, artificial sphincters, incontinence slings, pessaries and clamps and nerve stimulation devices. The incontinence care products and devices market is expected to face several challenges in coming years due to the advent of pharmaceutical products to combat incontinence. The Canadian Urological association and Pfizer Canada are developing a new fellowship program offering support and funding for Canadian urological researchers. Astellas Pharma Canada introduced Myrbetriq, a drug for urge incontinence. The growth stems from a demand for treatment of incontinence which is observed to be on a rise in recent years as there are approximately 27 to 30 million people of all ages suffering from incontinence.
Incontinence care market is challenged greatly by internal substitutes. There is a large variety of treatment methods available such as adult diapers, bulking injections, artificial sphincters, slings & meshes. Drugs such as Anticholinergic agents act on efferent nerves to counteract overactive bladder (OAB) after it occurs. To prevent the occurrence of OAB, therapies should be directed at blocking the afferent nerves that control the bladder. Bulking agents are expected to become a significant substitute treatment for incontinence in coming years and SA-BRC estimates the market to have greatest potential in the adult diapers, neurostimulation and bulking agents segment.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Overactive Bladder in 12 Major Markets Overactive Bladder (OAB) is a (relatively) common, disabling condition associated with significant ...
DelveInsight’s Urinary Incontinence - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Urinary Incontinence for the ...
Incontinence and ostomy care consist of products that are essential for patients with incontinence and stoma. With the projected rise in aged population and awareness about such conditions, the market ...